These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25426775)

  • 1. Generalized Lorentzian Tensor Approach (GLTA) as a biophysical background for quantitative susceptibility mapping.
    Yablonskiy DA; Sukstanskii AL
    Magn Reson Med; 2015 Feb; 73(2):757-64. PubMed ID: 25426775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of biological tissue structural anisotropy and anisotropy of magnetic susceptibility on the gradient echo MRI signal phase: theoretical background.
    Yablonskiy DA; Sukstanskii AL
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27862452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorentzian effects in magnetic susceptibility mapping of anisotropic biological tissues.
    Yablonskiy DA; Sukstanskii AL
    J Magn Reson; 2018 Jul; 292():129-136. PubMed ID: 29730126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic susceptibility induced white matter MR signal frequency shifts--experimental comparison between Lorentzian sphere and generalized Lorentzian approaches.
    Luo J; He X; Yablonskiy DA
    Magn Reson Med; 2014 Mar; 71(3):1251-63. PubMed ID: 23637001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint 2D and 3D phase processing for quantitative susceptibility mapping: application to 2D echo-planar imaging.
    Wei H; Zhang Y; Gibbs E; Chen NK; Wang N; Liu C
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26887812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative magnetic susceptibility mapping without phase unwrapping using WASSR.
    Lim IA; Li X; Jones CK; Farrell JA; Vikram DS; van Zijl PC
    Neuroimage; 2014 Feb; 86():265-79. PubMed ID: 24113625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating hyperoxic effects in the rat brain using quantitative susceptibility mapping based on MRI phase.
    Hsieh MC; Kuo LW; Huang YA; Chen JH
    Magn Reson Med; 2017 Feb; 77(2):592-602. PubMed ID: 26834053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.
    Deistung A; Schäfer A; Schweser F; Biedermann U; Turner R; Reichenbach JR
    Neuroimage; 2013 Jan; 65():299-314. PubMed ID: 23036448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic susceptibility anisotropy outside the central nervous system.
    Dibb R; Xie L; Wei H; Liu C
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27199082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint eigenvector estimation from mutually anisotropic tensors improves susceptibility tensor imaging of the brain, kidney, and heart.
    Dibb R; Liu C
    Magn Reson Med; 2017 Jun; 77(6):2331-2346. PubMed ID: 27385561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?
    Schweser F; Deistung A; Lehr BW; Reichenbach JR
    Neuroimage; 2011 Feb; 54(4):2789-807. PubMed ID: 21040794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
    Betts MJ; Acosta-Cabronero J; Cardenas-Blanco A; Nestor PJ; Düzel E
    Neuroimage; 2016 Sep; 138():43-63. PubMed ID: 27181761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of quantitative susceptibility mapping.
    Deistung A; Schweser F; Reichenbach JR
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27434134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
    Wang Y; Liu T
    Magn Reson Med; 2015 Jan; 73(1):82-101. PubMed ID: 25044035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
    Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
    J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Susceptibility Mapping: Concepts and Applications.
    Reichenbach JR; Schweser F; Serres B; Deistung A
    Clin Neuroradiol; 2015 Oct; 25 Suppl 2():225-30. PubMed ID: 26198880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility map-weighted imaging (SMWI) for neuroimaging.
    Gho SM; Liu C; Li W; Jang U; Kim EY; Hwang D; Kim DH
    Magn Reson Med; 2014 Aug; 72(2):337-46. PubMed ID: 24006248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gradient echo and gradient echo sampling of spin echo sequence for the quantification of the oxygen extraction fraction from a combined quantitative susceptibility mapping and quantitative BOLD (QSM+qBOLD) approach.
    Hubertus S; Thomas S; Cho J; Zhang S; Wang Y; Schad LR
    Magn Reson Med; 2019 Oct; 82(4):1491-1503. PubMed ID: 31155754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM).
    Schweser F; Deistung A; Reichenbach JR
    Z Med Phys; 2016 Mar; 26(1):6-34. PubMed ID: 26702760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of R
    Santin MD; Didier M; Valabrègue R; Yahia Cherif L; García-Lorenzo D; Loureiro de Sousa P; Bardinet E; Lehéricy S
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26913373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.